Cargando…
Effect of Ginkgolide in Ischemic Stroke patients with large Artery Atherosclerosis: Results from a randomized trial
BACKGROUND: Dual antiplatelet therapy is considered beneficial in acute ischemic stroke (AIS) patients with intracranial artery stenosis (ICAS), with more bleeding events. Ginkgolide is shown to reduce platelet activation after infarction, which might be of benefit in AIS. We aimed to explore the ef...
Autores principales: | Dong, Yi, Zhang, Jingyu, Wang, Yanxia, Zhao, Lihong, Li, Runhui, Wei, Chunhua, Bai, Qingke, Wan, Lishu, Sun, Liping, Feng, Shejun, You, Mingyao, Wang, Chun, Zhang, Hongtian, He, Qing, Yu, Ming, Dong, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611772/ https://www.ncbi.nlm.nih.gov/pubmed/34676982 http://dx.doi.org/10.1111/cns.13742 |
Ejemplares similares
-
Ginkgolide B Modulates BDNF Expression in Acute Ischemic Stroke
por: Wei, Hu, et al.
Publicado: (2017) -
Ginkgolide B Protects Against Ischemic Stroke via Targeting AMPK/PINK1
por: Cao, Yile, et al.
Publicado: (2022) -
The neuroprotective mechanisms of ginkgolides and bilobalide in cerebral ischemic injury: a literature review
por: Feng, Zili, et al.
Publicado: (2019) -
Transformation of multi-component ginkgolide into ginkgolide B by Coprinus comatus
por: Ding, HongXue, et al.
Publicado: (2015) -
Ginkgolide With Intravenous Alteplase Thrombolysis in Acute Ischemic Stroke Improving Neurological Function: A Multicenter, Cluster-Randomized Trial (GIANT)
por: Zhang, Xuting, et al.
Publicado: (2021)